NCT06580808

Brief Summary

This study will assess physical and respiratory capacity, diaphragmatic mobility and quality of life. Healthy children and children who have undergone Fontan surgery will participate. Some children in the late postoperative period of Fontan surgery will be randomized to a group of inspiratory muscle training that will last for 2 months. Children after Fontan surgery will be evaluated twice, once at the beginning and again after two months of follow-up.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 27, 2017

Completed
6.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 13, 2024

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 10, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 16, 2024

Completed
14 days until next milestone

First Posted

Study publicly available on registry

August 30, 2024

Completed
Last Updated

August 30, 2024

Status Verified

September 1, 2017

Enrollment Period

6.3 years

First QC Date

August 16, 2024

Last Update Submit

August 29, 2024

Conditions

Keywords

congenital heart diseaseFontan procedurerehabilitationphysiotherapyinspiratory muscle training

Outcome Measures

Primary Outcomes (1)

  • Assessment of the diaphragm muscle

    The mobility and thickness of the diaphragm muscle were assessed using ultrasound in M mode. Both variables were analyzed during spontaneous, relaxed breathing in terms of both tidal volume and deep breathing at vital capacity. Muscle mobility was examined along the right and left mid-axillary and parasternal lines with volunteers in both the supine and sitting positions. Muscle thickness was measured while the patients were in the supine position along the mid-axillary lines during both natural, relaxed and deep breathing. Measurements were taken in centimeters, with the largest value selected from at least three reproducible measurements.

    Baseline to 2 months

Secondary Outcomes (5)

  • Respiratory muscle strength

    Baseline to 2 months

  • Lung function test

    Baseline to 2 months

  • Six-minute walk test

    Baseline to 2 months

  • Change in quality of life measurement

    Baseline to 2 months

  • Improvement exercise tolerance and functional capacity (peak VO2)

    Baseline to 2 months

Study Arms (3)

Control Group

NO INTERVENTION

The control group consisted of 18 healthy children. These children underwent cardiopulmonary testing, spirometry, chest ultrasound to assess the diaphragm, 6-minute walk test, respiratory muscle strength and quality of life. These tests were performed to assess the results of these tests in patients without previous illnesses.

Fontan Training Group

ACTIVE COMPARATOR

The Fonta training group consisted of 14 children in the late postoperative period of Fontan surgery. These children underwent cardiopulmonary testing, spirometry, chest ultrasound to assess the diaphragm, 6-minute walk test, respiratory muscle strength and quality of life. These tests were performed at the initial stage and after two months of inspiratory muscle training to assess the results of these in postoperative patients and what changes the training could bring. The training was performed with the Power Breath device, the carda was quantified at 40% of the force exerted at maximum inspiratory pressure by manovacuometry. The patient was asked to perform 3 sets of 20 repetitions twice over the course of 7 days of the week. Monitoring was done in person and virtually, and the carda was increased according to the evaluator's perception of the ease of the exercise or if the patient reported it to be easy. The training lasted 2 months.

Other: Fontan Training Group

Fonta Control Group

NO INTERVENTION

The Fonta Control Group consisted of 13 children in the late postoperative period of Fontan surgery. These children underwent cardiopulmonary testing, spirometry, chest ultrasound to assess the diaphragm, 6-minute walk test, respiratory muscle strength and quality of life. These tests were performed at the initial stage and after two months to assess the results of these tests in postoperative patients and whether there was any normal behavior.

Interventions

The Fonta training group consisted of 14 children in the late postoperative period of Fontan surgery. These children underwent cardiopulmonary testing, spirometry, chest ultrasound to assess the diaphragm, 6-minute walk test, respiratory muscle strength and quality of life. These tests were performed at the initial stage and after two months of inspiratory muscle training to assess the results of these in postoperative patients and what changes the training could bring. The training was performed with the Power Breath device, the carda was quantified at 40% of the force exerted at maximum inspiratory pressure by manovacuometry. The patient was asked to perform 3 sets of 20 repetitions twice over the course of 7 days of the week. Monitoring was done in person and virtually, and the carda was increased according to the evaluator's perception of the ease of the exercise or if the patient reported it to be easy. The training lasted 2 months.

Fontan Training Group

Eligibility Criteria

Age8 Years - 12 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Age 8 to 12 years;
  • Both sexes;
  • No history of other heart disease;
  • No history of lung and musculoskeletal diseases;
  • \>1 year post-operative Fontan Surgery;
  • Clinically stable;
  • Absence of serious arrhythmias;
  • Medical clearance to participate in the study; The legal guardian has agreed to participate in the research and the child has consented

You may not qualify if:

  • Musculoskeletal alterations;
  • Patients with neurological sequelae;
  • Patients with genetic syndromes associated with cognitive or psychiatric disorders;
  • History of perioperative arrhythmias;
  • Patients with uncontrolled heart failure;
  • Recent angina;
  • Severe arrhythmia;
  • Hemoptysis;
  • Pulmonary hypertension;
  • Diaphragmatic plication;
  • Moderate to severe asthma.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Heart Intitute

São Paulo, 05403-900, Brazil

Location

MeSH Terms

Conditions

Heart Defects, Congenital

Condition Hierarchy (Ancestors)

Cardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Marcelo B Jatene, Manager

    Heart Institute, University of São Paulo

    STUDY DIRECTOR
  • Joao Bruno PD Silveira, Execution

    Heart Institute, University of São Paulo

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Patients in the Fontan group were randomized into the Fontan Training Group (FTG) and Fontan Control Group. The FTG performed inspiratory muscle training with the Power Breth device with an initial load of 40% of the maximum inspiratory pressure obtained by measuring the maximum inspiratory pressure by manovacuometry. The training lasted 2 months. The patient was asked to perform the training every day with 3 series of 20 breaths. The training was monitored in person and remotely by videoconference; the load was increased gradually when it was perceived that it was already easy or reported by the child.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 16, 2024

First Posted

August 30, 2024

Study Start

September 27, 2017

Primary Completion

January 13, 2024

Study Completion

June 10, 2024

Last Updated

August 30, 2024

Record last verified: 2017-09

Data Sharing

IPD Sharing
Will share

If any researcher has any questions about the research or wants to replicate it, I am available to clarify them. If any agency or entity has any questions about the results, they can be made available based on their confidentiality and ethical responsibility to be reanalyzed and reproduced.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
The data will be available for possible checks at any time from now on.
Access Criteria
To access the data, if necessary, simply make a formal request and describe the reason for doing so.

Locations